There have been no open-market insider trades at Marinus Pharmaceuticals, Inc. in the last 12 months.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | Braunstein Scott | CEO | Buy | 5,933 | $1.10 | $7K | SEC |
| Jan 23, 2025 | Ezickson Elan | Director | Sell | 1,600 | $0.54 | $864 | SEC |
| Jan 23, 2025 | Johnson Marvin | Director | Sell | 1,610 | $0.54 | $869 | SEC |
| Aug 7, 2024 | Shafer Christina | Executive Officer | Sell | 3,820 | $1.14 | $4K | SEC |
| Aug 7, 2024 | Pfanstiel Steven | CFO | Sell | 4,657 | $1.13 | $5K | SEC |
| Aug 7, 2024 | MANNING MARTHA E | Executive Officer | Sell | 3,621 | $1.13 | $4K | SEC |
| Aug 7, 2024 | Hulihan Joseph | Executive Officer | Sell | 4,828 | $1.13 | $5K | SEC |
| Aug 7, 2024 | Braunstein Scott | CEO | Sell | 12,145 | $1.13 | $14K | SEC |
| Feb 22, 2024 | Shafer Christina | Executive Officer | Sell | 2,153 | $9.56 | $21K | SEC |
| Feb 22, 2024 | MANNING MARTHA E | Executive Officer | Sell | 1,894 | $9.57 | $18K | SEC |
| Feb 21, 2024 | Hulihan Joseph | Executive Officer | Sell | 2,814 | $9.98 | $28K | SEC |
| Feb 21, 2024 | Pfanstiel Steven | CFO | Sell | 3,092 | $9.97 | $31K | SEC |
| Feb 21, 2024 | Braunstein Scott | CEO | Sell | 11,850 | $9.94 | $118K | SEC |
| Aug 8, 2023 | Pfanstiel Steven | CFO | Sell | 2,790 | $9.54 | $27K | SEC |
| Aug 8, 2023 | MANNING MARTHA E | Executive Officer | Sell | 2,169 | $9.54 | $21K | SEC |
There were no open-market insider trades in MRNS in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in MRNS were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).